Akihiro Tamori Selected Research

HLA-DPA1 antigen (HLA DPA1)

1/2014	New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia.
9/2013	HLA class II associated with outcomes of hepatitis B and C infections.
1/2012	Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiro Tamori Research Topics

Disease

58	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2002
41	Infections 10/2022 - 02/2002
39	Chronic Hepatitis C 10/2022 - 01/2002
25	Fibrosis (Cirrhosis) 10/2022 - 02/2002
23	Neoplasms (Cancer) 01/2021 - 03/2002
22	Chronic Hepatitis B 01/2022 - 06/2003
15	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 03/2002
14	Hepatitis 01/2022 - 03/2002
11	Hepatitis B 01/2022 - 06/2003
11	Liver Diseases (Liver Disease) 01/2021 - 03/2006
7	Chronic Hepatitis (Chronic Active Hepatitis) 12/2020 - 03/2002
6	Hepatitis C 09/2019 - 01/2004
5	Carcinogenesis 12/2020 - 08/2005
5	Inflammation (Inflammations) 12/2020 - 11/2004
5	Disease Progression 02/2020 - 12/2008
4	Virus Diseases (Viral Diseases) 07/2020 - 01/2013
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 11/2003 - 03/2002
3	Non-alcoholic Fatty Liver Disease 01/2021 - 09/2011
3	Hemorrhage 01/2021 - 01/2019
3	Esophageal and Gastric Varices (Esophageal Varices) 01/2019 - 10/2003
3	Anemia 08/2017 - 09/2011
2	Fatty Liver 01/2021 - 01/2017
2	Varicose Veins (Varicose Vein) 07/2020 - 09/2006
2	Hypoxia (Hypoxemia) 08/2019 - 10/2003
2	Liver Neoplasms (Liver Cancer) 01/2019 - 04/2015
2	Body Weight (Weight, Body) 06/2012 - 01/2012
2	Ascites 03/2012 - 07/2004
2	Osteoporosis 09/2007 - 04/2002
2	Idiopathic Noncirrhotic Portal Hypertension 05/2007 - 09/2003
2	Autoimmune Hepatitis 02/2007 - 02/2002
2	Thrombosis (Thrombus) 05/2003 - 07/2002
2	Metabolic Bone Diseases (Osteopenia) 04/2002 - 02/2002
2	Bone Diseases (Bone Disease) 04/2002 - 02/2002
1	Duodenal Ulcer (Curling's Ulcer) 02/2021
1	Bacteremia 02/2021

Drug/Important Bio-Agent (IBA)

37	InterferonsIBA 01/2020 - 01/2002
28	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2002
17	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2002
14	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 11/2008
11	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2021 - 04/2003
10	Lamivudine (Epivir)FDA Link 08/2015 - 05/2003
9	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2013
9	entecavir FDA Link 05/2019 - 12/2008
6	AntigensIBA 01/2022 - 12/2003
6	Biomarkers (Surrogate Marker)IBA 07/2021 - 02/2005
6	lenvatinibIBA 02/2021 - 08/2019
6	RNA (Ribonucleic Acid)IBA 12/2020 - 02/2002
5	NucleosidesIBA 01/2022 - 01/2006
5	Alanine Transaminase (SGPT)IBA 01/2021 - 07/2004
5	Hepatitis B e AntigensIBA 05/2018 - 05/2003
5	Proteins (Proteins, Gene)FDA Link 12/2014 - 01/2002
3	Immune Checkpoint ProteinsIBA 01/2022 - 01/2020
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2009
3	VaccinesIBA 01/2021 - 05/2013
3	BilirubinIBA 12/2020 - 01/2003
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 01/2013
3	Tenofovir (Viread)FDA Link 01/2020 - 04/2013
3	HLA-DPB1 antigen (HLA DPB1)IBA 01/2014 - 01/2012
3	HLA-DPA1 antigen (HLA DPA1)IBA 01/2014 - 01/2012
3	Branched-Chain Amino AcidsIBA 11/2009 - 03/2003
3	Serum AlbuminIBA 11/2009 - 03/2003
3	Tyrosine (L-Tyrosine)FDA Link 11/2009 - 03/2003
3	Vitamin K 2 (Vitamin K2)IBA 09/2007 - 04/2002
3	Interferon-alpha (Interferon Alfa)IBA 01/2006 - 01/2002
3	EnzymesIBA 01/2004 - 01/2002
3	AntibodiesIBA 12/2003 - 02/2002
2	SofosbuvirIBA 10/2022 - 01/2019
2	velpatasvirIBA 10/2022 - 01/2019
2	nasIBA 02/2021 - 09/2013
2	Collagen Type IV (Type IV Collagen)IBA 01/2021 - 05/2019
2	AlbuminsIBA 12/2020 - 01/2017
2	Carrier Proteins (Binding Protein)IBA 06/2020 - 08/2005
2	SteroidsIBA 08/2019 - 04/2008
2	HLA Antigens (Human Leukocyte Antigens)IBA 05/2019 - 01/2014
2	Fetal Proteins (Fetoprotein)IBA 05/2019 - 01/2017
2	Amino Acids FDA Link 01/2017 - 04/2015
2	Choline (Choline Chloride)IBA 01/2017 - 04/2015
2	Messenger RNA (mRNA)IBA 01/2017 - 11/2015
2	Indicators and Reagents (Reagents)IBA 08/2015 - 03/2003
2	Pharmaceutical PreparationsIBA 01/2015 - 10/2013
2	telaprevirIBA 01/2015 - 12/2014
2	Hemoglobins (Hemoglobin)IBA 01/2015 - 09/2011
2	Viral DNAIBA 05/2014 - 04/2003
2	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2014 - 05/2013
2	HLA-DP Antigens (HLA-DP)IBA 01/2014 - 01/2012
2	Coffee FDA Link 01/2013 - 11/2006
2	telomerase RNA (bTR)IBA 11/2009 - 03/2003
2	Ethanol (Ethyl Alcohol)IBA 03/2006 - 07/2002
2	Mitochondrial DNA (mtDNA)IBA 11/2004 - 01/2003
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2004 - 05/2003
2	PolyaminesIBA 01/2004 - 03/2002
2	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 11/2003 - 09/2003
2	Human Serum Albumin FDA LinkGeneric 09/2003 - 03/2002
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2021
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 02/2021

Therapy/Procedure

68	Therapeutics 02/2021 - 01/2002
5	Aftercare (After-Treatment) 01/2021 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2017 - 05/2003
2	Drug Tapering 08/2017 - 09/2011